SI-BONE, Inc. (FRA:2K3)
Germany flag Germany · Delayed Price · Currency is EUR
15.80
-0.10 (-0.63%)
At close: Dec 5, 2025

SI-BONE Company Description

SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.

The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products.

It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a proprietary 3D-printed porous surface and fenestrated design; iFuse TORQ, a line of 3D-printed threaded implants designed for applications in pelvic trauma and sacroliliac fusion; and iFuse Bedrock Granite Implant System that provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion; and iFuse TORQ TNT to treat pelvic trauma and sacroiliac joint dysfunction, as well as iFuse INTRA implants that are marketed as human cells, tissues, and cellular or tissue-based products.

The company markets its products primarily with a direct sales force, as well as through third-party sales agent and resellers.

SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

SI-BONE, Inc.
Country United States
Founded 2008
Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Employees 349
CEO Laura Francis

Contact Details

Address:
471 El Camino Real
Santa Clara, Delaware 95050
United States
Phone 408 207 0700
Website si-bone.com

Stock Details

Ticker Symbol 2K3
Exchange Frankfurt Stock Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
SIC Code 3842

Key Executives

Name Position
Laura Francis Chief Executive Officer
Anshul Maheshwari Chief Financial Officer
Saqib Iqbal Head of Investor Relations